Estrella Immunopharma Inc...
(ESLA)
undefined
undefined%
At close: undefined
1.15
-0.77%
After-hours Jan 06, 2025, 03:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Revenue | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a | n/a |
| Operating Income | -7.31M | -1.57M | -1.69M | -733.69K |
| Interest Income | n/a | 654.07K | 1.43K | n/a |
| Pretax Income | -7.31M | -915.46K | -1.69M | -733.69K |
| Net Income | -7.31M | -996.10K | -1.69M | -733.69K |
| Selling & General & Admin | 3.20M | 1.37M | 296.25K | 276.46K |
| Research & Development | 4.11M | n/a | 1.39M | 457.23K |
| Other Expenses | n/a | -201.31K | -70.15K | n/a |
| Operating Expenses | 7.31M | 1.57M | 1.69M | 733.69K |
| Interest Expense | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
| Cost & Expenses | 7.31M | 1.57M | 1.69M | 733.69K |
| Income Tax | 1.63K | 80.65K | -235.14K | -206.30K |
| Shares Outstanding (Basic) | 35.20M | 5.76M | 5.85M | 35.20M |
| Shares Outstanding (Diluted) | 35.20M | 5.76M | 5.85M | 35.20M |
| EPS (Basic) | -0.21 | -0.17 | -0.29 | -0.02 |
| EPS (Diluted) | -0.21 | -0.17 | -0.29 | -0.02 |
| EBITDA | -7.31M | -915.46K | -247.72K | -733.69K |
| Depreciation & Amortization | n/a | 228.49K | 236.56K | 206.30K |